Author:
Benatar Tania,Cao Ming Y.,Lee Yoon,Li Hui,Feng Ningping,Gu Xiaoping,Lee Vivian,Jin Hongnan,Wang Ming,Der Sandy,Lightfoot Jeff,Wright Jim A.,Young Aiping H.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference31 articles.
1. Ferdinandi ES, Braun DP, Liu C, Zee BC, Ely G (1999) Virulizin(R)—a review of its antineoplastic activity. Expert Opin Investig Drugs 8:1721–1735
2. Feng N, Jin H, Wang M, Du C, Wright JA, Young AH (2003) Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts. Cancer Chemother Pharmacol 51:247–255
3. Liu C, Ferdinandi ES, Ely G, Joshi SS (2000) Virulizin-2 gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts. Int J Oncol 16:1015–1020
4. Du C, Feng N, Jin H, Wang M, Wright JA, Young AH (2003) Preclinical efficacy of Virulizin in human breast, ovarian and prostate tumor models. Anticancer Drugs 14:289–294
5. Cao MY, Lee Y, Feng N, Li H, Du C, Miao D, Li J, Lee V, Jin H, Wang M, Gu X, Wright JA, Young AH (2005) NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin. Cancer Immunol Immunother 54:229–242
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献